TR199501599A2 - 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri. - Google Patents

17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri.

Info

Publication number
TR199501599A2
TR199501599A2 TR95/01599A TR9501599A TR199501599A2 TR 199501599 A2 TR199501599 A2 TR 199501599A2 TR 95/01599 A TR95/01599 A TR 95/01599A TR 9501599 A TR9501599 A TR 9501599A TR 199501599 A2 TR199501599 A2 TR 199501599A2
Authority
TR
Turkey
Prior art keywords
delivery
drug administration
administration devices
intravaginal drug
oestradiol precursor
Prior art date
Application number
TR95/01599A
Other languages
English (en)
Inventor
Allen Mcclay
Original Assignee
Galen Chemicals Ltd
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Galen Chemicals Ltd filed Critical Galen Chemicals Ltd
Publication of TR199501599A2 publication Critical patent/TR199501599A2/tr

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0034—Urogenital system, e.g. vagina, uterus, cervix, penis, scrotum, urethra, bladder; Personal lubricants
    • A61K9/0036—Devices retained in the vagina or cervix for a prolonged period, e.g. intravaginal rings, medicated tampons, medicated diaphragms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/565—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids not substituted in position 17 beta by a carbon atom, e.g. estrane, estradiol
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P15/00—Drugs for genital or sexual disorders; Contraceptives
    • A61P15/18—Feminine contraceptives

Landscapes

  • Health & Medical Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Reproductive Health (AREA)
  • Medicinal Chemistry (AREA)
  • Epidemiology (AREA)
  • Gynecology & Obstetrics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Endocrinology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Engineering & Computer Science (AREA)
  • Urology & Nephrology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
TR95/01599A 1994-12-19 1995-12-19 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri. TR199501599A2 (tr)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IES940976 1994-12-19
IES950247 1995-04-05

Publications (1)

Publication Number Publication Date
TR199501599A2 true TR199501599A2 (tr) 1996-07-21

Family

ID=26319777

Family Applications (1)

Application Number Title Priority Date Filing Date
TR95/01599A TR199501599A2 (tr) 1994-12-19 1995-12-19 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri.

Country Status (19)

Country Link
US (1) US5855906A (tr)
EP (1) EP0799025B1 (tr)
JP (1) JPH10510825A (tr)
CN (1) CN1138526C (tr)
AR (1) AR002010A1 (tr)
AT (1) ATE178204T1 (tr)
AU (1) AU692659B2 (tr)
CA (1) CA2207622C (tr)
DE (1) DE69508791T2 (tr)
DK (1) DK0799025T3 (tr)
ES (1) ES2133841T3 (tr)
FI (1) FI119414B (tr)
GR (1) GR3030614T3 (tr)
IL (1) IL116433A (tr)
NO (1) NO316707B1 (tr)
NZ (1) NZ298490A (tr)
PE (1) PE62796A1 (tr)
TR (1) TR199501599A2 (tr)
WO (1) WO1996019196A1 (tr)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6407082B1 (en) * 1996-09-13 2002-06-18 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a vitamin D compound
US6034074A (en) 1996-09-13 2000-03-07 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of a Vitamin D compound
US6511970B1 (en) 1996-09-13 2003-01-28 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of products that induce transforming growth factor-beta and/or apoptosis in the ovarian epithelium
US6028064A (en) 1996-09-13 2000-02-22 New Life Pharmaceuticals Inc. Prevention of ovarian cancer by administration of progestin products
US6765002B2 (en) 2000-03-21 2004-07-20 Gustavo Rodriguez Prevention of ovarian cancer by administration of products that induce transforming growth factor-β and/or apoptosis in the ovarian epithelium
PT981327E (pt) * 1997-05-07 2003-02-28 Galen Chemicals Ltd Dispositivos intravaginais de libertacao de farmacos para a administracao de testosterona e percursores da testosterona
US6039968A (en) * 1997-06-24 2000-03-21 Hoechst Marion Roussel Intravaginal drug delivery device
US20010044431A1 (en) * 2000-03-21 2001-11-22 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20040176336A1 (en) * 2000-03-21 2004-09-09 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US20050113351A1 (en) * 2000-03-21 2005-05-26 Rodriguez Gustavo C. Prevention of ovarian cancer by administration of products that induce biologic effects in the ovarian epithelium
US6811549B2 (en) 2001-02-16 2004-11-02 William H. Fleming Administration of therapeutic or diagnostic agents using interlabial pad
US6962908B2 (en) * 2001-12-21 2005-11-08 Warner Chilcott Company Inc. Oral pharmaceutical products containing 17 β-estradiol-3-lower alkanoate, method of administering the same and process of preparation
WO2003080019A1 (en) * 2002-03-27 2003-10-02 Galen (Chemicals) Limited Intravaginal reservoir drug delivery devices
GB0222522D0 (en) * 2002-09-27 2002-11-06 Controlled Therapeutics Sct Water-swellable polymers
AU2004233997C1 (en) * 2003-04-29 2014-01-30 Massachusetts Institiute Of Technology Methods and devices for the sustained release of multiple drugs
GB0417401D0 (en) 2004-08-05 2004-09-08 Controlled Therapeutics Sct Stabilised prostaglandin composition
WO2006084083A2 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Devices for delivering agents to a vaginal tract
WO2006084082A1 (en) * 2005-02-03 2006-08-10 Duramed Pharmaceuticals, Inc. Compositions of unconjugated estrogens and methods for their use
ES2400091T3 (es) 2005-08-11 2013-04-05 Massachusetts Institute Of Technology Dispositivo de suministro de fármacos intravesical y método
US20070077269A1 (en) * 2005-10-04 2007-04-05 Woodward John R Method of birth control and hormone regulation
EP3566742A1 (en) 2005-10-13 2019-11-13 Synthes GmbH Drug-impregnated encasement
GB0613333D0 (en) 2006-07-05 2006-08-16 Controlled Therapeutics Sct Hydrophilic polyurethane compositions
GB0613638D0 (en) * 2006-07-08 2006-08-16 Controlled Therapeutics Sct Polyurethane elastomers
WO2008007098A2 (en) * 2006-07-12 2008-01-17 Controlled Therapeutics (Scotland) Ltd. Drug delivery polymer with hydrochloride salt of clindamycin
GB0620685D0 (en) * 2006-10-18 2006-11-29 Controlled Therapeutics Sct Bioresorbable polymers
CA2698143C (en) 2007-06-26 2016-01-19 Warner Chilcott Company, Llc Intravaginal drug delivery devices for the delivery of macromolecules and water-soluble drugs
JP5560200B2 (ja) 2007-12-11 2014-07-23 マサチューセッツ インスチテュート オブ テクノロジー 膀胱および他の身体の小嚢又は管腔を治療するための埋め込み型薬物供給デバイス
BRPI0917135A2 (pt) * 2008-08-09 2015-11-10 Massachusetts Inst Technology dispositivo médico para extensão e retenção em uma vesícula seminal, duto ejaculatório, próstata ou vaso deferente de um paciente, uso de um elastômero reabsorvível, e, dispositivo de bomba osmótica.
AU2010256558B2 (en) 2009-06-03 2013-10-03 Forsight Labs, Llc Anterior segment drug delivery
MX2011013539A (es) 2009-06-26 2012-02-28 Taris Biomedical Inc Tabletas de farmaco solidas para dispositivos implantables para administrar farmacos.
US9017312B2 (en) 2009-09-10 2015-04-28 Taris Biomedical Llc Implantable device for controlled drug delivery
US8580294B2 (en) 2010-10-19 2013-11-12 International Partnership For Microbicides Platinum-catalyzed intravaginal rings
EP2663300B1 (en) 2011-01-10 2023-03-08 TARIS Biomedical LLC Lidocaine regimen for the use of sustained treatment of bladder pain and irritative voiding
US9107816B2 (en) 2011-02-04 2015-08-18 Taris Biomedical Llc Implantable device for controlled dissolution and diffusion of low solubility drug
CN103917202B (zh) 2011-09-14 2016-06-29 弗赛特影像5股份有限公司 眼插入件装置和方法
TWI590843B (zh) 2011-12-28 2017-07-11 信迪思有限公司 膜及其製造方法
US9750636B2 (en) 2012-10-26 2017-09-05 Forsight Vision5, Inc. Ophthalmic system for sustained release of drug to eye
BR112015022433B1 (pt) 2013-03-15 2022-06-21 Taris Biomedical Llc Dispositivo de liberação de droga intravesical
JP6456935B2 (ja) 2013-06-21 2019-01-23 デピュイ・シンセス・プロダクツ・インコーポレイテッド フィルム及び製造方法
HUE051336T2 (hu) 2013-08-19 2021-03-01 Taris Biomedical Llc Többadagos gyógyszeradagoló eszköz
CN104546668B (zh) * 2013-10-23 2019-03-05 国家卫生计生委科学技术研究所 液体硅橡胶为载体的药物缓控释系统的制备及应用
US10137031B2 (en) 2013-11-14 2018-11-27 International Partnership For Microbicides, Inc. Combination therapy intravaginal rings
CA2944436C (en) * 2014-04-01 2023-08-22 Poly-Med, Inc. Contraceptive and related device
EP3283004A4 (en) 2015-04-13 2018-12-05 Forsight Vision5, Inc. Ocular insert composition of semi-crystalline or crystalline pharmaceutically active agent
EP3285850A1 (en) 2015-04-23 2018-02-28 TARIS Biomedical LLC Drug delivery devices with drug-permeable component and methods

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3545439A (en) * 1968-01-04 1970-12-08 Upjohn Co Medicated devices and methods
US4291014A (en) * 1979-01-11 1981-09-22 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estradiol diacetate
US4438139A (en) * 1979-08-14 1984-03-20 Key Pharmaceuticals, Inc. Polymeric diffusion matrix containing estrogens
SE8602666D0 (sv) * 1986-06-16 1986-06-16 Leo Ab Intravaginal devices

Also Published As

Publication number Publication date
US5855906A (en) 1999-01-05
JPH10510825A (ja) 1998-10-20
AU692659B2 (en) 1998-06-11
ES2133841T3 (es) 1999-09-16
ATE178204T1 (de) 1999-04-15
NZ298490A (en) 1999-11-29
FI119414B (fi) 2008-11-14
CA2207622A1 (en) 1996-06-27
GR3030614T3 (en) 1999-10-29
IL116433A0 (en) 1996-03-31
DE69508791D1 (de) 1999-05-06
WO1996019196A1 (en) 1996-06-27
NO972798L (no) 1997-08-19
DE69508791T2 (de) 1999-12-02
AR002010A1 (es) 1998-01-07
FI972579A0 (fi) 1997-06-17
NO972798D0 (no) 1997-06-17
EP0799025A1 (en) 1997-10-08
CN1138526C (zh) 2004-02-18
IL116433A (en) 2002-02-10
AU4399196A (en) 1996-07-10
CA2207622C (en) 2006-10-17
NO316707B1 (no) 2004-04-13
FI972579A (fi) 1997-06-17
DK0799025T3 (da) 1999-10-18
PE62796A1 (es) 1996-12-28
CN1170353A (zh) 1998-01-14
EP0799025B1 (en) 1999-03-31

Similar Documents

Publication Publication Date Title
TR199501599A2 (tr) 17 -oestradiol ön maddesinin verilmesi icin vajina icine ilac uygulama aletleri.
IL157771A0 (en) Intravaginal drug delivery devices for the administration of an antimicrobial agent
ATE209497T1 (de) Azithromycin enthaltende arzneiverabreichungsformen mit gesteuerter wirkstoffabgabe
EE05506B1 (et) Ravimi manustamise vahend eriti progestiinide ja”strogeenide manustamiseks
GB9522403D0 (en) Intravaginal drug delivery device
TR27244A (tr) Ilac dagitim aleti.
HUP0204015A3 (en) Devices for the delivery of drugs having antiprogestinic properties
NO20004196L (no) Innretninger for legemiddelavlevering
DZ1876A1 (fr) Médicaments pour administration orale.
DE69923076D1 (de) Transthorakale arzneimittelabgabevorrichtung
DK1221919T3 (da) Oftalmisk lægemiddeladministrationsanordning
PL328399A1 (en) Drug administration aid
DE69427472D1 (de) Arzneimittel mit kontrollierter Wirkstoffabgabe
HUP0201637A3 (en) Novel preparation and administration form comprising an acid-labile active compound
NO20001219D0 (no) Blanding for medikament-administrasjon
EE05415B1 (et) Ravimi manustamise vahend, eriti androgeenide manustamiseks
FR2796287B1 (fr) Dispositif d'administration de medicament
DE69914472D1 (de) Levosimendanhaltige oral anzuwendende arzneimittel mit gesteuerter wirkstoffverabreichung
ZA9510787B (en) Intravaginal drug delivery devices for the administration of 17 beta-oestradiol precursors
KR950032276U (ko) 의약품 투여용 피부 흠집 형성구
GB9713360D0 (en) Intravaginal drug delivery device
GB9724777D0 (en) Intravaginal drug delivery device
GB9522402D0 (en) Intravaginal drug delivery device
GB9503322D0 (en) Medicament administration dummy
ZA931775B (en) Drug delivery devices.